Event Date/Time: Oct 07, 2013 End Date/Time: Oct 09, 2013
Early Registration Date: Sep 06, 2013
Abstract Submission Date: Sep 06, 2013
Report as Spam


Digital PCR, at its core, is simply a single molecule counting method that quantitatively measures absolute DNA and eliminates the need for standard curves. However, it has already shown potential to be a disruptive technology in many areas of diagnostics. The Second Annual Digital PCR event will bring together industry visionaries and early adopters to discuss digital PCR's capabilities, limitations, and future applications. Researchers will examine applications in cancer biomarker and rare mutation detection, non-invasive fetal DNA analysis, and infectious disease quantification, particularly in HIV. Novel digital PCR devices from startups and academic labs will be showcased. Other topics to be addressed include digital PCR integration with existing technologies, solutions for processing difficult samples as well as increasing sample throughput, and guidelines and best practices for digital detection.


1775 East Mission Bay Drive
San Diego
United States

Conference Speakers

  • Jim Huggett, B.Sc. (Hons), Ph.D., Science Leader, Nucleic Acid Metrology, Molecular & Cell Biology, LGC
  • Kerry R. Emslie, Ph.D., Bioanalysis Group Manager, National Measurement Institute, Australia
  • Ross Haynes, Biological Science Technician, Biochemical Science Division, National Institute of Standards and Technology
  • Alec Morely, Emeritus Professor, Haematology and Genetic Pathology, Flinders University
  • Filip Janku, M.D., Ph.D., Assistant Professor, Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center
  • Nickolas Papadopoulos, Ph.D., Professor, Oncology; Director, Translational Genetics, Ludwig Center for Cancer Genetics & Therapeutics, Sidney Kimmel Comprehensive Cancer Center
  • Valerie Taly, Ph.D., Group Leader/CNRS Researcher, Universit√© Paris-Descartes
  • Leonora Balaj, Ph.D., Researcher, Massachusetts General Hospital, Harvard Medical School
  • Philipp Angenendt, Ph.D., CTO, Inostics GmbH
  • Hanlee P. Ji, M.D., Assistant Professor, Medicine, Division of Oncology, Stanford University School of Medicine
  • Vicki Hwang, Graduate Student Researcher, Biochemistry and Molecular Medicine, University of California at Davis
  • Emmanuel Debrand, Ph.D., R&D Scientist (NIPD), West Midlands Genetics Laboratory, Birmingham Women's NHS Foundation Trust
  • Richard Novak, Researcher, Mathies Lab, University of California, Berkeley
  • David Dodd, Ph.D., Postdoctoral Fellow, Corey Lab, University of Texas, Southwestern
  • Donna C. Sullivan, Ph.D., Professor of Medicine, Division of Infectious Diseases, University of Mississippi Medical Center
  • Keith R. Jerome, M.D., Ph.D., Professor and Head, Virology Division, Department of Laboratory Medicine, University of Washington; Associate Member, Fred Hutchinson Cancer Research Center, Vaccine and Infectious Disease Division
  • Douglas D. Richman, M.D., Director, Center for AIDS Research; Distinguished Professor, Pathology and Medicine; Florence Seeley Riford Chair in AIDS Research, University of California, San Diego
  • Gary Lee, Ph.D., Scientist, Team Leader, Sangamo BioSciences
  • Andy Watson, Chief Commercial Officer, Raindance Technologies, Inc.
  • Feng Shen, Director, Research and Development, SlipChip LLC
  • Emil Kartalov, Ph.D., Assistant Professor, Pathology, Keck School of Medicine, University of Southern California
  • Hai-Qing Gong, Associate Professor, School of Mechanical and Aerospace Engineering, Nanyang Technological University